|
|
Volumn 62, Issue 6, 1996, Pages 1575-1577
|
|
Aprotinin: Safe and effective only with the full-dose regimen
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APROTININ;
CEREBROVASCULAR ACCIDENT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
CREATININE BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
HEART INFARCTION;
HUMAN;
MAJOR CLINICAL STUDY;
MORTALITY;
PRIORITY JOURNAL;
APROTININ;
BLOOD LOSS, SURGICAL;
CORONARY ARTERY BYPASS;
HEMOSTATICS;
HUMANS;
MYOCARDIAL INFARCTION;
|
|
EID: 0029729898
PISSN: 00034975
EISSN: None
Source Type: Journal
DOI: 10.1016/S0003-4975(96)00958-7 Document Type: Editorial |
|
Times cited : (86)
|
|
References (0)
|
